Sarcopenia and Frailty in Patients Undergoing Transcatheter Aortic Valve Replacement

Heart, Artery and Coronary DiseasesTherapy and Intervention

The impact of elevated C-reactive protein levels on long-term outcomes of patients undergoing transcatheter aortic valve replacement

Cardiovasc Revasc Med

Brunner S, Moccetti F, Loretz L, Conrad N, Bossard M, Attinger-Toller A, Kurmann R, Cuculi F, Wolfrum M, Toggweiler S

doi: 10.1016/j.carrev.2024.07.002

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Aortic Stenosis and Cardiogenic Shock

Eur Heart J Acute Cardiovasc Care

Ismayl M, Ahmed H, Goldsweig AM, Eleid MF, Guerrero M, Rihal CS

doi: 10.1093/ehjacc/zuae103

Heart, Artery and Coronary DiseasesTherapy and Intervention

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

J Am Coll Cardiol

Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators

doi: 10.1016/j.jacc.2025.03.004

Heart, Artery and Coronary DiseasesTherapy and InterventionFurther Publications

Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement

JAMA Cardiol

Solla-Suarez P, Arif SG, Ahmad F, Rastogi N, Meng A, Cohen JM, Rodighiero J, Piazza N, Martucci G, Lauck S, Webb JG, Kim DH, Kovacina B, Afilalo J

doi: 10.1001/jamacardio.2024.0911

Heart, Artery and Coronary DiseasesFurther Publications

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Clin Res Cardiol

Saad M, Seoudy H, Bramlage K, Bramlage P, Voran JC, Puehler T, Lutter G, Allali A, Landt M, Frank J, Bisht O, Salem M, Wienemann H, Adam M, Zeus T, Veulemans V, Bleiziffer S, Rudolph TK, Frank D

doi: 10.1007/s00392-025-02611-w

Heart FailureTherapy and Intervention

Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation

N Engl J Med

Raposeiras-Roubin S, Amat-Santos IJ, Rossello X, González Ferreiro R, González Bermúdez I, Lopez Otero D, Nombela-Franco L, Gheorghe L, Diez JL, Baladrón Zorita C, Baz JA, Muñoz García AJ, Vilalta V, Ojeda-Pineda S, de la Torre Hernández JM, Cordoba Soriano JG, Regueiro A, Bordes Siscar P, Salgado Fernández J, Garcia Del Blanco B, Martín-Reyes R, Romaguera R, Moris C, García Blas S, Franco-Peláez JA, Cruz-González I, Arzamendi D, Romero Rodríguez N, Díez-Del Hoyo F, Camacho Freire S, Bosa Ojeda F, Astorga Burgo JC, Molina Navarro E, Caballero Borrego J, Ruiz Quevedo V, Sánchez-Recalde Á, Peral Disdier V, Alegría-Barrero E, Torres-Llergo J, Feltes G, Fernández Díaz JA, Cuellas C, Jiménez Britez G, Sánchez-Rubio Lezcano J, Barreiro-Pardal C, Núñez-Gil I, Abu-Assi E, Iñiguez-Romo A, Fuster V, Ibáñez B, DapaTAVI Investigators

doi: 10.1056/NEJMoa2500366

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Transcatheter Aortic Valve Replacement on Cardiac Reverse Remodeling and Prognosis in Mixed Aortic Valve Disease

J Am Heart Assoc

Saijo Y, Kusunose K, Takahashi T, Yamada H, Sata M, Sato K, Albakaa N, Ishizu T, Seo Y, JSE‐TAVI investigators *

doi: 10.1161/JAHA.123.033289

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transfemoral-only transcatheter aortic valve replacement: A single center experience of 400 consecutive patients

Catheter Cardiovasc Interv

Moccetti F, Wolfrum M, Bossard M, Attinger-Toller A, Loretz L, Cuculi F, Toggweiler S

doi: 10.1002/ccd.31077

Heart, Artery and Coronary DiseasesTherapy and Intervention

Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry

Circulation

Vekstein AM, Wegermann ZK, Manandhar P, Mack MJ, Cohen DJ, Hughes GC, Harrison JK, Kaneko T, Kapadia SR, Stathogiannis K, Fearon WF, Arnold S, Kosinski AS, Leon MB, Batchelor WB, Thourani VH, Vemulapalli S

doi: 10.1161/CIRCULATIONAHA.124.071838

Related content

The impact of elevated C-reactive protein levels on long-term outcomes of patients undergoing transcatheter aortic valve replacement

Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Aortic Stenosis and Cardiogenic Shock

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation

Impact of Transcatheter Aortic Valve Replacement on Cardiac Reverse Remodeling and Prognosis in Mixed Aortic Valve Disease

Transfemoral-only transcatheter aortic valve replacement: A single center experience of 400 consecutive patients

Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry